J&J's EmboTrap Clot Retriever Gets US Green Light

16 May 2018
News

Tina Tan @MedtechTinaTan tina.tan@informa.com

Executive Summary

Johnson & Johnson has added the Embotrap clot retrieval device to its US offering after the product got FDA clearance. It will compete with Medtronic's Solitaire and Stryker's Trevo, which are already on the US market.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Device Areas
Neurology
Subjects
Approvals
Research & Development
Industries
Medical Device

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Neurology Approvals Research & Development

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT122679

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT122679

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

J&J's EmboTrap Clot Retriever Gets US Green Light

News

Executive Summary

Related Content

ISC 2018: ARISE II Supports J&J's EmboTrap Stent-Retriever

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert